I meant to ask this question at the AGM, but forgot. There have been a number of posts that have mentioned that GNH may be the "Poster Child" for Actlabs' SGH assay technique. Does anyone know whether we are getting priority assay timelines from Actlabs as it seems it would be in their best interest to promote this technology with a proof of principle approach?
Best,
Scott